This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kass: Defending Cramer

"This above all: to thine own self be true, and it must follow, as the night the day, thou canst not then be false to any man."
-- William Shakespeare

Late last week I asked Jim Cramer for permission to write a column in response to what I would describe as an abusive and ad hominem attack on him, Cramer vs. Cramer: Will His Crazy Confession Destroy His Career? written in Slate.com on March 22 by former Merrill Lynch Internet analyst Henry Blodget.

Though I did send a draft of today's column to him last evening, Jim gave me permission to respond to Blodget on my own terms. I give Jim credit for being willing to have me resurrect a story I am sure he is very angry about and wishes was never written. Nevertheless, he provided no input for today's opening missive nor was he given the opportunity by me to edit or make recommendations for this column.

As most subscribers now recognize, after six years on The Edge ( RealMoolah and Street Insight), I speak my mind and I am not easily influenced. Though I am employed as a consultant by the company that Jim founded (he is the largest shareholder and member of the board of directors), TheStreet.com., to my knowledge Jim has no control whatsoever of my content nor the content of any other contributor on TheStreet.com, Real Money or Street Insight. Nor does he control how I or any other contributor on the three sites are compensated or who is employed (or fired!).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
GE $27.28 0.04%
AAPL $130.54 0.20%
FB $80.29 1.39%
GOOG $533.99 0.35%
TSLA $249.45 -0.54%

Markets

DOW 18,040.37 +29.69 0.16%
S&P 500 2,111.73 +4.34 0.21%
NASDAQ 5,082.9290 +12.9030 0.25%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs